EDAP
Edap Tms S.a. NASDAQ Listed Aug 1, 1997$4.75
+0.64%
vs $4.72
Mkt Cap $177.9M
52w Low $1.25
95.6% of range
52w High $4.91
50d MA $3.93
200d MA $3.33
P/E (TTM)
—
EV/EBITDA
—
P/B
9.2x
Debt/Equity
1.4x
ROE
-150.7%
P/FCF
-9.5x
RSI (14)
64.30
ATR (14)
$0.26
Beta
-0.08
50d MA
$3.93
200d MA
$3.33
Avg Volume
43.1K
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.
Parc d’Activites la Poudrette-Lamartine · Vaulx-en-Velin, I0 69120 · FR
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 3.60 | -2.5% | +15.6% | -0.7% | +1.0% | -2.2% | +2.0% | — |
| Mar 25, 2026 | AMC | -0.16 | -0.25 | -56.2% | 3.71 | +5.9% | +1.6% | -1.1% | -2.9% | +2.8% | -5.1% | — |
| Nov 6, 2025 | AMC | -0.26 | -0.15 | +42.3% | 1.99 | +3.5% | +1.5% | +0.5% | -0.5% | +0.0% | +5.0% | — |
| Aug 28, 2025 | AMC | -0.18 | -0.17 | +5.6% | 1.82 | +3.8% | +24.2% | +22.1% | -0.4% | -8.4% | +0.0% | — |
| May 15, 2025 | AMC | -0.16 | -0.20 | -25.0% | 1.76 | -0.6% | +0.0% | +5.7% | +2.2% | -8.4% | +3.4% | — |
| Mar 27, 2025 | AMC | -0.11 | -0.05 | +54.5% | 2.22 | +3.2% | -3.2% | -8.8% | +0.0% | -4.6% | +2.1% | — |
| Nov 7, 2024 | AMC | -0.16 | -0.19 | -18.8% | 2.73 | -2.9% | -5.9% | -1.2% | +3.9% | -0.4% | -4.2% | — |
| Aug 28, 2024 | AMC | -0.14 | -0.18 | -28.6% | 2.99 | +5.0% | +9.0% | +11.0% | -3.6% | -8.0% | -2.2% | — |
| May 16, 2024 | AMC | -0.10 | -0.13 | -30.0% | 6.89 | +0.3% | -2.6% | -7.2% | -3.5% | +0.2% | -1.8% | — |
| Mar 27, 2024 | AMC | -0.05 | -0.15 | -229.0% | 7.10 | +0.0% | +3.5% | +2.9% | +0.1% | +2.6% | +1.9% | — |
| Nov 9, 2023 | AMC | -0.11 | -0.12 | -9.1% | 5.26 | -1.1% | -4.6% | -15.7% | -1.9% | +18.8% | -4.7% | — |
| Aug 24, 2023 | AMC | -0.05 | -0.14 | -178.3% | 8.08 | +0.2% | +0.7% | -2.1% | +1.5% | -0.2% | -0.2% | — |
| May 17, 2023 | AMC | -0.03 | -0.22 | -594.2% | 11.00 | +0.5% | -5.5% | -0.3% | -0.1% | -3.6% | +0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $3.37 | $3.56 | +5.6% | -0.3% | -1.8% | +0.9% | +1.2% | +4.5% |
| Apr 4 | Jefferies | Downgrade | Buy → Hold | — | $1.91 | $1.89 | -1.0% | -15.7% | -9.9% | +0.7% | +4.1% | -4.6% |
| Mar 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.22 | $2.29 | +3.2% | -3.2% | -8.8% | +0.0% | -4.6% | +2.1% |
| Mar 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.22 | $2.29 | +3.2% | -3.2% | -8.8% | +0.0% | -4.6% | +2.1% |
| Aug 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.99 | $3.14 | +5.0% | +9.0% | +11.0% | -3.6% | -8.0% | -2.2% |
| Jul 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.10 | $4.90 | -3.9% | -2.5% | -7.0% | +3.2% | -1.9% | -0.6% |
| May 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.89 | $6.91 | +0.3% | -2.6% | -7.2% | -3.5% | +0.2% | -1.8% |
| Apr 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.35 | $7.58 | +3.1% | +2.9% | +0.1% | +2.6% | +1.9% | +2.9% |
| Nov 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.26 | $5.20 | -1.1% | -4.6% | -15.7% | -1.9% | +18.8% | -4.7% |
| Aug 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.08 | $8.10 | +0.2% | +0.7% | -2.1% | +1.5% | -0.2% | -0.2% |
| Jun 12 | Lake Street | Maintains | Buy → Buy | — | $9.00 | $8.93 | -0.8% | +0.2% | +1.7% | -1.1% | +0.0% | +1.3% |
| Jun 1 | Lake Street | Maintains | Buy → Buy | — | $9.94 | $9.92 | -0.2% | +0.9% | -0.7% | -0.6% | -1.9% | -1.9% |
| May 18 | Lake Street | Maintains | Buy → Buy | — | $11.00 | $11.06 | +0.5% | -5.5% | -0.3% | -0.1% | -3.6% | +0.3% |
| May 1 | Lake Street | Maintains | Buy → Buy | — | $10.77 | $10.88 | +1.1% | +3.0% | +0.5% | +2.8% | -0.4% | +4.6% |
| Apr 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.55 | $10.70 | +1.4% | +3.1% | -2.0% | -0.6% | +0.4% | +0.6% |
| Feb 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.21 | $11.36 | +1.3% | +1.8% | +0.3% | +2.0% | -0.7% | +0.9% |
| Dec 6 | Lake Street | Maintains | Buy → Buy | — | $11.01 | $11.02 | +0.1% | -0.8% | -0.7% | +0.4% | +2.0% | -0.2% |
| Nov 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.34 | $10.25 | -0.9% | -3.8% | +5.0% | +1.5% | +1.6% | -0.4% |
| Nov 1 | Jefferies | Maintains | Buy → Buy | — | $9.48 | $9.50 | +0.2% | -0.5% | +8.9% | +0.6% | -1.7% | +1.6% |
| Nov 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.76 | $5.53 | -4.0% | -6.6% | +1.1% | +2.8% | +0.7% | -1.4% |
| Apr 28 | Piper Sandler | Maintains | Overweight → Overweight | — | $7.33 | $7.42 | +1.2% | -1.2% | -0.3% | -4.7% | -1.7% | -0.9% |
| Apr 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.40 | $8.96 | +6.7% | +2.0% | +7.1% | +3.9% | -4.3% | +1.6% |
| Jan 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.25 | $8.23 | -0.2% | -1.7% | -1.0% | +7.2% | -2.0% | -7.5% |
| Nov 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.13 | $4.18 | +1.2% | +1.0% | -1.9% | +3.7% | -1.2% | -1.7% |
| Apr 15 | B. Riley | Maintains | Buy → Buy | — | $2.25 | $2.41 | +6.9% | -1.1% | -6.3% | +1.4% | -0.9% | +1.0% |
| Apr 1 | H.C. Wainwright | Maintains | Buy → Buy | — | $2.27 | $2.26 | -0.4% | -5.5% | -1.6% | -0.5% | +4.0% | -2.1% |
| Jul 28 | Northland Capital Markets | Downgrade | Outperform → Market Perform | — | $4.88 | $4.72 | -3.3% | -25.2% | +1.1% | -7.3% | -43.9% | -4.2% |
| Jul 28 | Northland Securities | Downgrade | Outperform → Market Perform | — | $4.88 | $4.72 | -3.3% | -25.2% | +1.1% | -7.3% | -43.9% | -4.2% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | LEVINE JOSHUADir | — | Buy | 10,000 | $4.22 | $42K | 35,000 | -0.72% | -1.62% |
8-K · 8.01
!! High
Edap Tms S.a. -- 8-K 8.01: Material Event / Announcement
May 29
8-K · 2.02
!! High
Edap Tms S.a. -- 8-K 2.02: Earnings Results
Edap TMS announced Q1 2026 financial results and will host a conference call to discuss operational performance and financial condition with investors.
May 7
8-K · 5.02
!!! Very High
EDAP TMS SA -- 8-K 5.02: Executive Change
EDAP TMS appointed Glen French and David Horn as directors, strengthening board governance as the medical device company navigates market competition and strategic initiatives.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Soleus Capital Management, L.p. | 7,309,254 | $27M | — | Mar 2026 |
| 2 | Morgan Stanley | 6,704,160 | $22M | — | Dec 2025 |
| 3 | Flax Pond Capital, Llc | 783,446 | $3M | New | Mar 2026 |
| 4 | Bruce & Co., Inc. | 438,652 | $2M | — | Mar 2026 |
| 5 | Ubs Group Ag | 169,630 | $631K | Reduced | Mar 2026 |
| 6 | Cahill Financial Advisors Inc | 134,960 | $502K | — | Mar 2026 |
| 7 | Us Bancorp \de\ | 119,000 | $392K | New | Dec 2025 |
| 8 | Summit Trail Advisors, Llc | 102,339 | $381K | — | Mar 2026 |
| 9 | Leonteq Securities Ag | 94,990 | $353K | — | Mar 2026 |
| 10 | Commonwealth Equity Services, Llc | 69,160 | $228K | — | Dec 2025 |
| 11 | Eversource Wealth Advisors, Llc | 2,643 | $100K | New | Mar 2026 |
| 12 | Bnp Paribas Financial Markets | 23,105 | $86K | Reduced | Mar 2026 |
| 13 | Accredited Investors Inc. | 21,431 | $80K | — | Mar 2026 |
| 14 | Kovack Advisors, Inc. | 16,000 | $60K | — | Mar 2026 |
| 15 | Composition Wealth, Llc | 13,500 | $50K | — | Mar 2026 |
| 16 | Simplicity Wealth,llc | 11,125 | $41K | Reduced | Mar 2026 |
| 17 | Financial Planning Navigators Corp | 10,043 | $33K | New | Dec 2025 |
| 18 | Valley National Advisers Inc | 3,800 | $14K | — | Mar 2026 |
| 19 | Wells Fargo & Company/mn | 3,500 | $13K | New | Mar 2026 |
| 20 | Harbor Investment Advisory, Llc | 500 | $2K | — | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 1
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index Fund | 22,764 | $99K | Feb 2026 |
Valuation
Market Cap
$177.9M
Enterprise Value
$176.3M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.08x
P/B
9.16x
P/S
2.47x
P/FCF
-9.46x
EV/EBITDA
—
Shares Out
37.4M
Financials (TTM)
Revenue
$72.0M
Net Income
-$30.0M
EBITDA
-$23.5M
Free Cash Flow
-$18.8M
Op Cash Flow
-$13.9M
EPS Basic
$-0.78
EPS Diluted
$-0.77
EPS Forward
$-0.65
Gross Margin
43.5%
Op Margin
-34.6%
Net Margin
-41.7%
Balance Sheet
Total Assets
$79.0M
Total Liab.
$59.6M
Total Equity
$19.4M
Cash
$17.4M
LT Debt
$15.9M
Book Value/Sh
$0.52
Debt/Equity
1.43x
Current Ratio
1.54
Quick Ratio
1.25
Returns & Growth
ROE
-150.7%
ROA
-37.0%
ROIC
-49.2%
Rev Growth YoY
+10.3%
EPS Growth YoY
-52.9%
Price Returns
2W
+4.6%
1M
+30.1%
3M
-1.1%
6M
+80.0%
12M
+142.7%
Technicals
52W High
$4.91
52W Low
$1.25
50d MA
$3.93
200d MA
$3.33
RSI (14)
64.30
ATR (14)
$0.26
Beta
-0.08
Avg Volume
43K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.00
High
$10.00
Low
$2.00
Median
$6.00
Data updated apr 26, 2026 10:24am
· Source: financialmodelingprep.com